Spitfire Pharma, Inc. — Form D

Spitfire Pharma, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-11. The offering totals $9.5M, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2013-01-11
• Form: D
• Accession: 0001566043-13-000001
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $9.5M
• Amount sold: $500K
• Remaining: $9.0M
• Investors: 1
• Date of first sale: 2012-12-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-190044

Issuer

• Name: Spitfire Pharma, Inc.
• CIK: 0001566043
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2011
• Address: 400 OYSTER POINT BOULEVARD SUITE 202, SOUTH SAN FRANCISCO, CA, 94080
• Phone: 415-689-5709

Officers, directors & promoters (2)

More

• CIK 1566043 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search